Biocryst Pharmaceuticals (BCRX) Other Operating Expenses (2012 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Other Operating Expenses came in at $703.1 million in Q1 2026, up 15292.69% YoY from N/an in Q1 2025, and up 7284.35% on a QoQ basis from $9.5 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Other Operating Expenses (2012 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 15 years of Other Operating Expenses data on file, last reported at $703.1 million in Q1 2026.
- Quarterly Other Operating Expenses rose 15292.69% year-over-year to $703.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $717.6 million (up 4508.56% YoY) and the FY2025 annual result came in at $19.1 million, up 55.47% from the prior year.
- Other Operating Expenses grew to $703.1 million in Q1 2026, from $9.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $703.1 million in Q1 2026 to a low of $238000.0 in Q1 2022.
- A 5-year average of $43.9 million and a median of $2.2 million in 2025 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses sank 95.96% — and 2026, when it jumped 15292.69%.
- Tracing BCRX's Other Operating Expenses over 5 years: stood at $2.5 million in 2022, then sank by 41.63% to $1.5 million in 2023, then jumped by 318.26% to $6.1 million in 2024, then soared by 56.25% to $9.5 million in 2025, then soared by 7284.35% to $703.1 million in 2026.
- The last three Other Operating Expenses figures came in at $703.1 million (Q1 2026), $9.5 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.84 Mn |
| Mar 31, 2026 | 703.14 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Sep 30, 2025 | 2.19 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 4.57 Mn |
| Dec 31, 2024 | 6.09 Mn |
| Sep 30, 2024 | 3.21 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 950,000.00 |
| Mar 31, 2023 | 938,000.00 |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 3.61 Mn |
| Jun 30, 2022 | 247,000.00 |
| Mar 31, 2022 | 238,000.00 |
| Dec 31, 2021 | 419,000.00 |
| Sep 30, 2021 | 615,000.00 |